Zamproni Ilaria, Grasberger Helmut, Cortinovis Francesca, Vigone Maria Cristina, Chiumello Giuseppe, Mora Stefano, Onigata Kazumichi, Fugazzola Laura, Refetoff Samuel, Persani Luca, Weber Giovanna
Laboratory of Pediatric Endocrinology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
J Clin Endocrinol Metab. 2008 Feb;93(2):605-10. doi: 10.1210/jc.2007-2020. Epub 2007 Nov 27.
Dual oxidase 2 (DUOX2) is the catalytic core of the H(2)O(2) generator crucial for the iodination of thyroglobulin in thyroid hormone synthesis. DUOX2 deficiency produces congenital hypothyroidism (CH) in humans and mice. We recently cloned a novel gene, the product of which (dual oxidase maturation factor 2; DUOXA2) is required to express DUOX2 enzymatic activity.
Our objective was to identify DUOXA2 mutations as a novel cause of CH due to dyshormonogenesis.
Subjects included 11 CH patients with partial iodine organification defect but negative for other known genetic causes of partial iodine organification defect.
One Chinese patient born to nonconsanguineous parents was homozygous for a nonsense mutation (p.Y246X), producing a truncated DUOXA2 protein lacking transmembrane helix 5 and the C-terminal cytoplasmic domain. The mutant protein was inactive in reconstituting DUOX2 in vitro. Pedigree analysis demonstrated recessive inheritance, because heterozygous carriers had normal thyroid function including negative results in neonatal TSH screening. One heterozygous carrier of Y246X was identified in unrelated Chinese controls (n = 92) but not in Caucasian or Japanese controls, indicating that homozygosity for Y246X could be a frequent cause of CH in Chinese. Functional studies suggest that the DUOXA2 paralog (DUOXA1) can partially compensate DUOXA2 deficiency, consistent with the proband having a milder CH phenotype than patients with biallelic DUOX2 nonsense mutations.
We report the first mutation in DUOXA2, identified in a patient with CH and dyshormonogenic goiter. Results of our studies provide evidence for the critical role of DUOXA2 in thyroid hormonogenesis. Biallelic DUOXA2 mutations are a novel genetic event in permanent CH.
双氧化酶2(DUOX2)是甲状腺激素合成过程中甲状腺球蛋白碘化所必需的过氧化氢生成酶的催化核心。DUOX2缺乏会导致人类和小鼠出现先天性甲状腺功能减退症(CH)。我们最近克隆了一个新基因,其产物(双氧化酶成熟因子2;DUOXA2)是表达DUOX2酶活性所必需的。
我们的目的是确定DUOXA2突变是由于激素合成障碍导致CH的新病因。
研究对象包括11例CH患者,这些患者存在部分碘有机化缺陷,但其他已知的部分碘有机化缺陷的遗传病因检测呈阴性。
一名非近亲结婚父母所生的中国患者,其双等位基因存在无义突变(p.Y246X),导致产生截短的DUOXA2蛋白,该蛋白缺少跨膜螺旋5和C端胞质结构域。该突变蛋白在体外重建DUOX2时无活性。家系分析显示为隐性遗传,因为杂合子携带者甲状腺功能正常,包括新生儿促甲状腺激素筛查结果为阴性。在无关的中国对照组(n = 92)中鉴定出一名Y246X杂合子携带者,而在白种人或日本对照组中未发现,这表明Y246X纯合子可能是中国CH的常见病因。功能研究表明,DUOXA2旁系同源物(DUOXA1)可部分补偿DUOXA2缺乏,这与先证者的CH表型比双等位基因DUOX2无义突变患者的表型较轻一致。
我们报道了在一名CH和激素合成障碍性甲状腺肿患者中鉴定出的首例DUOXA2突变。我们的研究结果为DUOXA2在甲状腺激素生成中的关键作用提供了证据。双等位基因DUOXA2突变是永久性CH中的一种新的遗传事件。